Reproduced from here.

Table 1 – Randomized and single-arm phase 2 trials that reported outcome for various RKC subtypes

(This is the original unedited version written for KCCure)

Forty years ago, MIT accepted me to grad school.

I was a “local boy” raised in Texas, working in my teenage years with my father in refineries in the Houston area. I remember remarking to my Dad, “A whole lot of people die early from kidney cancer in this job”.